Cases & Deals

Celularity acquires certain assets from TNK Therapeutics

Clients Celularity Inc.

Jones Day advised Celularity Inc. in connection with its acquisition from TNK Therapeutics of certain intellectual property rights related to TNK's proprietary chimeric antigen receptor ("CAR") constructs and related CARs.